| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total revenues | 17,062 | 18,418 | ||
| Cost of sales | 3,187 | 3,469 | ||
| Gross profit | 13,875 | 14,949 | ||
| Sales and marketing | 12,053 | 14,314 | ||
| General and administrative | 7,227 | 6,666 | ||
| Research and development | 3,748 | 5,117 | ||
| Total operating expenses | 23,028 | 26,097 | ||
| Operating loss | -9,153 | -11,148 | ||
| Interest expense | 1,268 | 1,252 | ||
| Other (expense) income, net | -2,751 | 2,484 | ||
| Loss before income taxes | -13,172 | -9,916 | ||
| Income tax (expense) benefit | 15 | 4 | ||
| Net loss | -13,187 | -9,920 | ||
| Basic | -0.46 | -0.38 | ||
| Diluted | -0.46 | -0.38 | ||
| Weighted average number of shares outstanding, basic, total | 28,393,445 | 26,367,548 | ||
| Weighted average number of shares outstanding, diluted, total | 28,393,445 | 26,367,548 | ||
AVITA Medical, Inc. (RCEL)
AVITA Medical, Inc. (RCEL)